Medtronic has received Health Canada approval for ablation frontiers cardiac ablation system, a radiofrequency (RF) ablation technology for the treatment of atrial fibrillation (AF).
The Medtronic ablation frontiers cardiac ablation system tools approved for use in Canada include GENius multi-channel radiofrequency generator and the pulmonary vein ablation catheter (PVAC), an anatomically shaped mapping and ablation catheter designed to efficiently isolate the pulmonary veins to treat AF.
The GENius generator and PVAC, with the addition of the Multi-Array Septal Catheter (MASC) and Multi-Array Ablation Catheter (MAAC), are available in Europe and are under investigational use in the US.
Medtronic is expected to provide periodic clinical updates on the safety and effectiveness of the PVAC catheter as a condition of Health Canada’s approval.
Medtronic AF Solutions vice president and general manager Reggie Groves said that as one of the latest tools in Medtronic’s growing AF Solutions portfolio, the company’s aim is to provide physicians with easy-to-use ablation technologies that help them safely treat those suffering from AF, when used as indicated.